Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

por Fousekis, Fotios S., Theopistos, Vasileios I., Mitselos, Ioannis V., Skamnelos, Alexandros, Kavvadias, Athanasios, Katsanos, Konstantinos H., Christodoulou, Dimitrios K.
Publicado 2019

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience

por Migkos, Michalis P., Kaltsonoudis, Evripidis, Pelechas, Eleftherios, Drossou, Vassiliki, Karagianni, Panagiota G., Kavvadias, Athanasios, Voulgari, Paraskevi V., Drosos, Alexandros A.
Publicado 2021

Clostridium Difficile Infection in Patients Impact Suspected Cytomegalovirus Infection in Patients with Inflammatory Bowel Disease

por Kosmidou, Maria, Karavasili, Nicoletta T., Saridi, Maria, Skamnelos, Alexandros, Kavvadias, Athanasios, Batistatou, Anna, Gartzonika, Konstantina G., Tsiara, Stavroula, Katsanos, Konstantinos H., Christodoulou, Dimitrios K.
Publicado 2020